Precision Medicine in Oncology® | Specialty

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Managing Toxicities With Immunotherapy in CRC

February 26th 2018

Dosing and Side Effect Management in Metastatic CRC

February 26th 2018

Third-Line Treatment in Refractory CRC

February 26th 2018

Immunotherapy Options in Refractory CRC

February 26th 2018

Supportive Care in Metastatic CRC

February 26th 2018

Maintenance and Second-Line Decisions in CRC

February 26th 2018

Frontline Antibody Selection in Metastatic CRC

February 26th 2018

Left- Versus Right-Sided Tumors in CRC

February 26th 2018

Importance of HER2 Expression in CRC

February 26th 2018

Role of Molecular Testing in CRC Management

February 26th 2018

Early-Onset CRC: What Do We Know?

February 26th 2018

Treating Liver or Peritoneal Metastases in CRC

February 26th 2018

Managing Patients After Adjuvant Therapy

February 26th 2018

Duration of Adjuvant Therapy: CRC Subsets

February 26th 2018

Deciding on Adjuvant Therapy in CRC

February 26th 2018

Gastrointestinal Cancers Entering Age of Precision Medicine

February 21st 2018

Aiwu Ruth He, MD, PhD, discusses the future of precision medicine in gastrointestinal cancers.

Take-Home Messages on Breast Oncology Advances

February 17th 2018

Immunotherapy for Triple-Negative Breast Cancer

February 17th 2018

PARP Inhibitors for BRCA-Mutated TNBC

February 17th 2018

Advantages with Nab-Paclitaxel in TNBC

February 17th 2018